Johns Hopkins Model Predicts HIV Comorbidities | AIDS 2024
Keri Althoff, Ph.D., discusses how a model developed at Johns Hopkins can assess the comorbidities that patients with HIV may face by 2030.
Patients with HIV who have diabetes or chronic kidney disease are at a higher risk for myocardial infarction than a patient with HIV who does not have these comorbidities, Keri Althoff, Ph.D., professor, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, said in an interview ahead of the International AIDS Conference.
During the conference, which is being held in Munich Germany, Althoff presented about the modeling her team did on the prevalence of comorbidities for people with HIV.
Althoff and her team developed a mathematical model that considered risk factor such body mass index, smoking and hepatitis C, as well as dyslipidemia, hypertension, diabetes, and stage three or greater chronic kidney disease to help predict the comorbidities that patients with HIV may face by 2030.
Today, the clade 2b outbreak has reached alarming proportions, with over 94,000 confirmed cases reported across 117 countries, including significant numbers in the U.S. and Brazil, and up to 103 deaths. The virus has been found to affect younger men who have sex with men, who are linked to high rates of HIV co-infection.
Read More
With PrEP Effort Lagging, Positive Results for Twice-Yearly Lenacapavir May Give a Lift | AIDS 2024
July 25th 2024Phase 3 trials reported at the International AIDS Society meeting this week show no infections among those randomly assigned to twice-year injections of lenacapavir and no reason to be worried about safety,.
Read More
